Incidence of venous thromboembolism in patients with colorectal cancer according to oncogenic status.

Laura Ortega MoránP García AlfonsoI Aguilar CaballeroB Morón GarcíaV Tirado AnulaM de Toro CarmenaJ Soto AlsarN Gutiérrez AlonsoM Bringas BeranekM Martín JiménezAndrés Muñoz Martin

Published in: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico (2020)

In our study, biomarkers have not been associated with an increased risk of VTE in CRC patients. A high incidence of VTE in BRAF-mutated patients has been observed and should be explored in further studies.

Keyphrases

venous thromboembolism
end stage renal disease
ejection fraction
chronic kidney disease
peritoneal dialysis
prognostic factors
risk factors
direct oral anticoagulants